Fundamental dimension Equity attribute | BONLPeer $0.950.00% Cap $1.66MP/E 27.5x QuantScore43/100 | ADHCPeer $0.0005▲+6.38% Cap $1.20MP/E -2.5x QuantScore18/100 | ANMPLeader $0.40▲+0.00% Cap $1.48MP/E 1.9x QuantScore63/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
35/100 |
52/100 |
31/100 |
Valuation Multiples, PEG & DCF upside | 57/100 | 0/100 | 100/100 |
Health Piotroski, Altman Z, leverage & liquidity | 56/100 | 20/100 | 71/100 |
Growth Revenue / earnings growth & margins | 25/100 | 0/100 | 52/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 27.5x | -2.5x | 1.9x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -48.7x | -1.3x | -1.4x |
Price / Sales | 1.0x | — | 0.4x |
Price / Free Cash Flow | 9.3x | — | 2.7x |
PEG ratio | -0.07 | -0.05 | 0.01 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 2 / 9 | 7 / 9 |
Altman Z-Score | 3.41 (Safe) | -601.28 (Distress) | -18.56 (Distress) |
Total debt / equity | 0.22 | -0.07 | 0.00 |
Quick ratio | 3.9x | 0.0x | 53.0x |
Interest coverage | -25.6x | -635.8x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -26.4% | — | +18.6% |
Net income growth YoY | -183.5% | -38.5% | +228.8% |
Gross margin (TTM) | 69.8% | 0.0% | 47.6% |
Operating margin (FY) | -19.0% | — | 19.5% |
FCF margin (FY) | -7.3% | — | 14.1% |
5. Trailing price performancePrice change over period |
1M return | +5.6% | +25.0% | 0.0% |
3M return | -5.0% | +25.0% | 0.0% |
6M return | -15.2% | -16.7% | 0.0% |
Year to date | +5.6% | -16.7% | 0.0% |
1Y return | +11.8% | -77.8% | 0.0% |
3Y return | +58.3% | -62.7% | 0.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $0.5863 -38.3% premium | $-0.0019 -482.8% premium | $0.8992 +124.8% upside |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |